Endocrine Society GUIDELINES Bundle (free trial)

Lipid Management in Endocrine Disorders

Endocrine Society GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1356565

Contents of this Issue

Navigation

Page 5 of 21

Assessment 6 Figure 1. CVD Events per 1,000 Person-Years by Strata of CAC and LDL-C CAC predicts ASCVD risk independent of LDL-C. Patients with lower LDL-C but higher CAC remain high risk, while patients with higher LDL-C but CAC=0 remain low risk. Source: Reproduced with permission from Martin SS, Blaha M, Blankenstein R, Agatston A, Rivera JJ, Virani SS, Ouyang P, Jones SR, Blumenthal RS, Budoff MJ, Nasir K. "Dyslipidemia, CAC, and incident ASCVD: implications for statin therapy from the multi-ethnic study of atherosclerosis." Circulation, 2014; 129(1):77-86.

Articles in this issue

Archives of this issue

view archives of Endocrine Society GUIDELINES Bundle (free trial) - Lipid Management in Endocrine Disorders